We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA approved Adamas Pharmaceuticals’ Gocovri (amantadine) for the treatment of dyskinesia in Parkinson’s disease patients receiving levodopa therapy, making it the first drug to be approved for that condition. Read More
Consumers find short lists of drug risks in broadcast advertising easier to recall, according to a new study by researchers at the FDA and RTI International’s Center for Communication Science. Read More
The FDA cited a Montreal drugmaker for refusing to allow an FDA inspector to take photographs during an inspection — and said that alone can lead to a finding that products are adulterated. Read More
A United States appeals court revived an antitrust lawsuit against four drugmakers alleging that they hamstrung generics for Lipitor and Effexor XR. Read More
Democrats in the Michigan Legislature outlined their plan for state review of large drug price hikes Aug. 21 hoping to push their state into similar efforts in Ohio and California. Read More